St. Jude Medical Receives Consensus Recommendation of “Hold” from Brokerages (NYSE:STJ)
Shares of St. Jude Medical (NYSE:STJ) have been given an average rating of “Hold” by the twenty-two ratings firms that are presently covering the stock, AnalystRatingsNetwork.com reports. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and ten have given a buy rating to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $69.67.
STJ has been the subject of a number of recent research reports. Analysts at Sterne Agee initiated coverage on shares of St. Jude Medical in a research note on Tuesday, July 29th. They set a “neutral” rating and a $74.00 price target on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of St. Jude Medical in a research note on Thursday, July 17th. They now have a $81.00 price target on the stock, up previously from $74.00. Finally, analysts at Zacks reiterated a “neutral” rating on shares of St. Jude Medical in a research note on Thursday, July 17th. They now have a $71.00 price target on the stock.
Shares of St. Jude Medical (NYSE:STJ) opened at 64.87 on Monday. St. Jude Medical has a one year low of $49.94 and a one year high of $71.90. The stock’s 50-day moving average is $65.85 and its 200-day moving average is $65.69. The company has a market cap of $18.468 billion and a price-to-earnings ratio of 20.91.
St. Jude Medical (NYSE:STJ) last posted its quarterly earnings results on Wednesday, July 16th. The company reported $1.02 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.00 by $0.02. The company had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.44 billion. During the same quarter in the prior year, the company posted $0.96 earnings per share. The company’s quarterly revenue was up 3.2% on a year-over-year basis. Analysts expect that St. Jude Medical will post $4.00 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, October 31st. Stockholders of record on Tuesday, September 30th will be paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 1.66%. The ex-dividend date is Friday, September 26th.
St. Jude Medical, Inc (NYSE:STJ) develops, manufactures and distributes cardiovascular medical devices.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.